FDA Inspection 992914 — Hisun Pharmaceutical Hangzhou Co., Ltd
The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on October 27, 2016 in Hangzhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 27, 2016
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Hangzhou (China)